Essential role for Bim in mediating the apoptotic and antitumor activities of immunotoxins
- 24 April 2017
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 36 (35) , 4953-4962
Abstract
Protein synthesis is crucial for regulating cell homeostasis and, when unrestricted, it can lead to tumorigenesis. Immunotoxins derived from Pseudomonas exotoxin are antibody–toxin fusion proteins that inhibit protein synthesis of mammalian cells via ADP-ribosylation of the eukaryotic elongation factor-2. Here we investigate the role of the Bcl-2 family proteins in the response of cancer cells to immunotoxin challenge. Besides the well-known reduction of the prosurvival Bcl-2 family member, Mcl-1, following inhibition of protein synthesis, we show for the first time that immunotoxins also reduce the levels of selected proapoptotic BH-3-only proteins. Among these, only Bim protein levels correlated with the ability of immunotoxins to induce an apoptotic response. To support our findings, we verified that a Bim knockout completely abolished immunotoxin-mediated apoptosis. Further, mice bearing either wild-type or Bid knockout tumors responded to immunotoxin treatment with a decrease in growth kinetics, whereas mice engrafted with Bim knockout tumors showed no reduction in tumor size or prolongation of survival following immunotoxin treatment. From these results, we conclude that Bim expression is a major susceptibility factor for tumor cell death and, as such, constitutes a potential biomarker that could be evaluated before immunotoxin treatment. In support of this hypothesis, clinically, we analyzed patient cells before immunotoxin treatment and report that samples of hairy cell leukemia with high levels of Bim protein responded with a greater decrease in leukemic cell count compared with those samples expressing a low level of Bim.Keywords
This publication has 24 references indexed in Scilit:
- Immunotoxins: The Role of the ToxinToxins, 2013
- Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributorCell Death & Disease, 2012
- Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell LeukemiaJournal of Clinical Oncology, 2012
- Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug ConjugatesCancer Research, 2011
- A guide to taming a toxin – recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancerThe FEBS Journal, 2011
- BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death ProgramScience, 2010
- ABT-737 Overcomes Resistance to Immunotoxin-Mediated Apoptosis and Enhances the Delivery of Pseudomonas Exotoxin–Based Proteins to the Cell CytosolMolecular Cancer Therapeutics, 2010
- The BCL-2 Family ReunionMolecular Cell, 2010
- Bcl-2-regulated apoptosis: mechanism and therapeutic potentialCurrent Opinion in Immunology, 2007
- Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinaseBiochemical and Biophysical Research Communications, 2002